Workflow
Countdown to Waste Management (WM) Q1 Earnings: Wall Street Forecasts for Key Metrics
ZACKS· 2025-04-23 22:21
Wall Street analysts forecast that Waste Management (WM) will report quarterly earnings of $1.65 per share in its upcoming release, pointing to a year-over-year decline of 5.7%. It is anticipated that revenues will amount to $6.11 billion, exhibiting an increase of 18.4% compared to the year-ago quarter.Over the last 30 days, there has been an upward revision of 0.6% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration ...
Gear Up for Woodward (WWD) Q2 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-04-23 22:21
Wall Street analysts forecast that Woodward (WWD) will report quarterly earnings of $1.44 per share in its upcoming release, pointing to a year-over-year decline of 11.1%. It is anticipated that revenues will amount to $830.26 million, exhibiting a decline of 0.6% compared to the year-ago quarter.Over the last 30 days, there has been an upward revision of 0.4% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of thei ...
Gear Up for Cadence (CDNS) Q1 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-04-23 22:21
In its upcoming report, Cadence Design Systems (CDNS) is predicted by Wall Street analysts to post quarterly earnings of $1.49 per share, reflecting an increase of 27.4% compared to the same period last year. Revenues are forecasted to be $1.24 billion, representing a year-over-year increase of 22.7%.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of th ...
Curious about NXP (NXPI) Q1 Performance? Explore Wall Street Estimates for Key Metrics
ZACKS· 2025-04-23 22:21
Analysts on Wall Street project that NXP Semiconductors (NXPI) will announce quarterly earnings of $2.59 per share in its forthcoming report, representing a decline of 20.1% year over year. Revenues are projected to reach $2.83 billion, declining 9.6% from the same quarter last year.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this ...
Unlocking Q1 Potential of Ameris Bancorp (ABCB): Exploring Wall Street Estimates for Key Metrics
ZACKS· 2025-04-23 22:21
In its upcoming report, Ameris Bancorp (ABCB) is predicted by Wall Street analysts to post quarterly earnings of $1.15 per share, reflecting an increase of 4.6% compared to the same period last year. Revenues are forecasted to be $278.8 million, representing a year-over-year increase of 3.9%.The current level reflects an upward revision of 0.8% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initia ...
Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Poster for Cema-Cel at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire News Room· 2025-04-23 22:12
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced that it will present updated data from the completed Phase 1 TRAVERSE trial of ALLO-316 in an oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29-June 2 in Chicago, Illinois. The trial e ...
Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting
GlobeNewswire News Room· 2025-04-23 22:12
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that the following presentations related to emiltatug ledadotin (Emi-Le; XMT-1660), Mersana’s B7-H4-directed Dolasynthen ADC, will be given at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting taking ...
First Hawaiian (FHB) Q1 Earnings and Revenues Surpass Estimates
ZACKS· 2025-04-23 22:10
文章核心观点 - 第一夏威夷银行本季度财报表现超预期,股价年初至今表现不佳,未来走势取决于管理层财报电话会议评论及盈利预期变化,当前Zacks评级为持有,同行业哥伦比亚银行即将公布财报 [1][3][6] 第一夏威夷银行财报情况 - 本季度每股收益0.47美元,超Zacks共识预期0.46美元,去年同期为0.42美元,本季度盈利惊喜为2.17%,上一季度盈利惊喜为2.50% [1] - 过去四个季度,公司四次超共识每股收益预期 [2] - 截至2025年3月季度营收2.11亿美元,超Zacks共识预期0.32%,去年同期为2.058亿美元,过去四个季度公司三次超共识营收预期 [2] 第一夏威夷银行股价表现 - 年初至今,第一夏威夷银行股价下跌约10.3%,而标准普尔500指数下跌10.1% [3] 第一夏威夷银行未来展望 - 股票近期价格走势及未来盈利预期主要取决于管理层财报电话会议评论 [3] - 盈利前景可帮助投资者判断股票走向,包括当前季度共识盈利预期及预期近期变化 [4] - 近期盈利预估修正趋势与短期股价走势强相关,投资者可自行跟踪或借助Zacks评级工具 [5] - 财报发布前,盈利预估修正趋势喜忧参半,当前Zacks评级为3(持有),预计短期内股票表现与市场一致 [6] - 未来需关注未来季度和本财年盈利预估变化,当前未来季度共识每股收益预估为0.49美元,营收2.1447亿美元,本财年共识每股收益预估为1.97美元,营收8.6521亿美元 [7] 行业情况 - Zacks行业排名中,西部银行行业目前处于250多个Zacks行业的后43%,研究显示排名前50%的行业表现比后50%的行业好两倍多 [8] 哥伦比亚银行情况 - 哥伦比亚银行预计4月24日公布截至2025年3月季度财报,预计本季度每股收益0.63美元,同比变化-3.1%,过去30天该季度共识每股收益预估未变 [9] - 预计哥伦比亚银行本季度营收4.813亿美元,较去年同期增长1.6% [10]
Amphenol (APH) Q1 Earnings and Revenues Top Estimates
ZACKS· 2025-04-23 22:10
Amphenol (APH) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.40 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 21.15%. A quarter ago, it was expected that this maker of fiber-optic products would post earnings of $0.50 per share when it actually produced earnings of $0.55, delivering a surprise of 10%.Over the last four quarters, t ...
Norfolk Southern (NSC) Lags Q1 Earnings Estimates
ZACKS· 2025-04-23 22:10
文章核心观点 - 诺福克南方公司本季度财报有盈有亏,股价短期走势取决于管理层财报电话会议评论,当前Zacks评级为卖出,未来表现受行业前景影响;加拿大太平洋堪萨斯城公司即将公布财报,市场有相关预期 [1][3][6] 诺福克南方公司财报情况 - 本季度每股收益2.69美元,未达Zacks共识预期的2.72美元,去年同期为2.49美元,本季度盈利意外为 -1.10% [1] - 上一季度预期每股收益2.95美元,实际为3.04美元,盈利意外为3.05% [1] - 过去四个季度,公司三次超出共识每股收益预期 [2] - 截至2025年3月季度营收29.9亿美元,超Zacks共识预期0.06%,去年同期为30亿美元,过去四个季度公司两次超出共识营收预期 [2] 诺福克南方公司股价表现 - 自年初以来,诺福克南方公司股价下跌约6.3%,而标准普尔500指数下跌 -10.1% [3] 诺福克南方公司未来展望 - 公司股票短期价格走势取决于管理层财报电话会议评论 [3] - 投资者可通过公司盈利前景判断股票走向,盈利前景包括当前对未来季度的共识盈利预期及预期变化 [4] - 近期盈利预估修正趋势与短期股价走势强相关,投资者可自行跟踪或借助Zacks评级工具 [5] - 财报发布前,公司盈利预估修正趋势不利,当前Zacks评级为4(卖出),预计短期内股价表现逊于市场 [6] - 未来季度和本财年盈利预估变化值得关注,当前未来季度共识每股收益预期为3.21美元,营收31亿美元,本财年共识每股收益预期为12.75美元,营收123.7亿美元 [7] 行业情况 - Zacks行业排名中,运输 - 铁路行业目前处于250多个Zacks行业前17%,排名前50%的行业表现优于后50%超两倍 [8] 加拿大太平洋堪萨斯城公司情况 - 该公司尚未公布截至2025年3月季度财报,预计4月30日发布 [9] - 预计本季度每股收益0.74美元,同比增长7.3%,过去30天本季度共识每股收益预估上调0.8% [9] - 预计本季度营收26.6亿美元,较去年同期增长2% [10]